Antiretroviral activity of thiosemicarbazone metal complexes

Journal of Medicinal Chemistry

Volumn 53, Issue 24, 2010, Pages 8765-8769

  Pelosi, Giorgio ^a   Bisceglie, Franco ^a   Bignami, Fabio ^b   Ronzi, Paola ^b   Schiavone, Pasqualina ^c   Re, Maria Carla ^c   Casoli, Claudio ^b,d   Pilotti, Elisabetta ^d  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d GEMIB Laboratory   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AQUA(PYRIDOXALTHIOSEMICARBAZONATO)COPPER; BIS(CITRONELLALTHIOSEMICARBAZONATO)NICKEL; METAL COMPLEX; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; STRUCTURE ACTIVITY RELATION; VIROGENESIS; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CELL SURVIVAL; COORDINATION COMPLEXES; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; LEUKOCYTES, MONONUCLEAR; STRUCTURE-ACTIVITY RELATIONSHIP; THIOSEMICARBAZONES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 78650362914     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1007616     Document Type: Article

References (26)

1. Beraldo, H.; Gambino, D. The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes Mini Rev. Med. Chem. 2004, 4, 31-39 (Pubitemid 38842592)
2. Pelosi, G. Thiosemicarbazone Metal Complexes: From Structure to Activity Open Crystallogr. J. 2010, 3, 16-28
3. Kune, G. A. To-Day's Drugs: Methisazone Br. Med. J. 1964, 2, 621
4. Finkielsztein, L. M.; Castro, E. F.; Fabian, L. E.; Moltrasio, G. Y.; Campos, R. H.; Cavallaro, L. V.; Moglioni, A. G. New 1-indanone thiosemicarbazone derivatives active against BVDV Eur. J. Med. Chem. 2008, 43, 1767-1773
5. McLean, D. M. Vaccinia complications and methisazone therapy Clin. Infect. Dis. 2006, 42, 1653
6. Quenelle, D. C.; Keith, K. A.; Kern, E. R. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections Antiviral Res. 2006, 71, 24-30
7. Sebastian, L.; Desai, A.; Shampur, M. N.; Perumal, Y.; Sriram, D.; Vasanthapuram, R. N -Methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo Virol. J. 2008, 5, 64
8. Horton, D.; Varela, O. Cu, Pt, and Pd complexes of the 3-deoxy-1,2-bis(thiosemicarbazone) derived from d -glucose Carbohydr. Res. 2000, 328, 425-429
9. Genova, P.; Varadinova, T.; Matesanz, A. I.; Marinova, D.; Souza, P. Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growth Toxicol. Appl. Pharmacol. 2004, 197, 107-112
10. Mishra, V.; Pandeya, S. N.; Pannecouque, C.; Witvrouw, M.; De Clercq, E. Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (±)-3-menthone Arch. Pharm. (Weinheim, Germany) 2002, 335, 183-186 (Pubitemid 34847510)
11. Bal, T. R.; Anand, B.; Yogeeswari, P.; Sriram, D. Synthesis and evaluation of anti-HIV activity of isatin beta-thiosemicarbazone derivatives Bioorg. Med. Chem. Lett. 2005, 15, 4451-4455
12. Soriano, V.; Vallejo, A.; Gutierrez, M.; Tuset, C.; Cilla, G.; Martinez-Zapico, R.; Dronda, F.; Caballero, E.; Calderon, E.; Aguilera, A.; Martin, A. M.; Llibre, J.; del Romero, J.; Ortiz de Lejarazu, R.; Ulloa, F.; Eiros, J.; Gonzalez-Lahoz, J. Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group Eur. J. Epidemiol. 1996, 12, 625-629
13. Magnani, G.; Elia, G. F.; Casoli, C.; Calzetti, C.; Degli Antoni, A.; Donatini, A.; Fiaccadori, F. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression Eur. J. Epidemiol. 1995, 11, 527-533
14. Zella, D.; Mori, L.; Sala, M.; Ferrante, P.; Casoli, C.; Magnani, G.; Achilli, G.; Cattaneo, E.; Lori, F.; Bertazzoni, U. HTLV-II infection in Italian drug abusers Lancet 1990, 336, 575-576
15. Turci, M.; Pilotti, E.; Ronzi, P.; Magnani, G.; Boschini, A.; Parisi, S. G.; Zipeto, D.; Lisa, A.; Casoli, C.; Bertazzoni, U. Coinfection with HIV-1 and human T-cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS JAIDS, J. Acquired Immune Defic. Syndr. 2006, 41, 100-106
16. Bartholomew, C.; Blattner, W.; Cleghorn, F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad Lancet 1987, 2, 1469 (Pubitemid 18010356)
17. Buschini, A.; Pinelli, S.; Pellacani, C.; Giordani, F.; Ferrari, M. B.; Bisceglie, F.; Giannetto, M.; Pelosi, G.; Tarasconi, P. Synthesis, characterization and deepening in the comprehension of the biological action mechanisms of a new nickel complex with antiproliferative activity J. Inorg. Biochem. 2009, 103, 666-677
18. Belicchi Ferrari, M.; Gasparri Fava, G.; Pelizzi, C.; Tarasconi, P.; Tosi, G. Thiosemicarbazones as co-ordinating agents. Part 2. Synthesis, spectroscopic characterization, and X-ray structure of aquachloro(pyridoxal thiosemicarbazone)manganese(II) chloride and aqua(pyridoxal thiosemicarbazonato) -copper(II) chloride monohydrate J. Chem. Soc., Dalton Trans. 1987, 1, 227-233
19. Tarasconi, P.; Capacchi, S.; Pelosi, G.; Cornia, M.; Albertini, R.; Bonati, A.; Dall'Aglio, P. P.; Lunghi, P.; Pinelli, S. Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones Bioorg. Med. Chem. 2000, 8, 157-162
20. Martinez, M.; Augsburger, L.; Johnston, T.; Jones, W. W. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations Adv. Drug Deliv. Rev. 2002, 54, 805-824 (Pubitemid 35284012)
21. Martin, A. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences, 4th ed.; Lea and Febiger: Philadelphia, 1993.
22. Tetko, I. V.; Gasteiger, J.; Todeschini, R.; Mauri, A.; Livingstone, D.; Ertl, P.; Palyulin, V. A.; Radchenko, E. V.; Zefirov, N. S.; Makarenko, A. S.; Tanchuk, V. Y.; Prokopenko, V. V. Virtual computational chemistry laboratory - design and description J. Comput.-Aided Mol. Des. 2005, 19, 453-463
23. Berger, E. A.; Murphy, P. M.; Farber, J. M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 1999, 17, 657-700
24. Bangham, C. R. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 J. Gen. Virol. 2003, 84, 3177-3189
25. Salemi, M.; Vandamme, A. M.; Desmyter, J.; Casoli, C.; Bertazzoni, U. The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy Gene 1999, 234, 11-21
26. Pascu, S. I.; Waghorn, P. A.; Conry, T. D.; Lin, B.; Betts, H. M.; Dilworth, J. R.; Sim, R. B.; Churchill, G. C.; Aigbirhio, F. I.; Warren, J. E. Cellular confocal fluorescence studies and cytotoxic activity of new Zn(II) bis(thiosemicarbazonato) complexes Dalton Trans. 2008, 16, 2107-2110